pcn poster

Posters

This observational, noninterventional, prospective study described the person-centered experience of symptoms and impact of dementia-related psychosis (DRP) on patients from a patient and...

Victor Abler , DO;

Teresa Brandt , PhD;

Theresa Frangiosa , MBA;

Virginia Biggar , BA;

Angela Taylor , BA;

Bill Keller , MBA;

10/08/2020

Efficacy of Cariprazine in Patient Subgroups: Post Hoc Analysis of 3 Randomized, Placebo-Controlled Trials in Patients With Bipolar Depression

Introduction: Cariprazine is a dopamine D3-preferring D3/D2 and serotonin 5-HT1A receptor partial agonist approved to treat bipolar depression. The efficacy of cariprazine in patients wit...

Vladimir Maletic , MD;

Lakshmi Yatham , MBBS, FRCPC, MRCP, MBA;

Rakesh Jain , MD, MPH, RD;

Willie Earley , MD;

Mehul Patel , MD, PharmD;

Mauricio Tohen , MD, DrPH, MBA;

10/08/2020

Drivers of Prescribing Long-Acting Injectable Antipsychotics to Patients with Schizophrenia

Long-acting injectable (LAI) antipsychotics are recommended by clinical guidelines for patients with schizophrenia who struggle with adherence and/or recurrent relapses. However, LAI util...

Alexander Keenan , MA, MS, MD;

Dee Lin , PharmD, MS;

Jason Shepherd , BA;

Hollie Bailey , BSc;

Jack Wright ;

Carmella Benson , MSc, MS, MSHP;

Katy Bacon ;

Edward S. Kim , MD, FACP, MBA;

10/08/2020

Depressive Symptoms – Could it be Bipolar Depression? An Overview for Primary Care

Depression is often the initial and predominant disease presentation in patients with bipolar disorder leading to their frequent misdiagnosis with major depressive disorder. Primary care ...

Charles Brendan Montano , MD;

Donna Rolin , PhD, APRN, PMHNP-BC;

Mehul Patel , MD, PharmD;

Andrea Wilson , PharmD, BCPS, PhD;

10/08/2020

Efficacy and Safety of Lumateperone (ITI-007) in the Treatment of Depressive Episodes Associated With Bipolar I and II Disorders

Background: Treatments for bipolar depression are limited. Lumateperone (lumateperone tosylate, ITI-007), a mechanistically novel antipsychotic that simultaneously modulates serotonin, do...

Joseph Calabrese , MD;

Suresh Durgam , MD;

Robert Davis , PhD;

Andrew Satlin , MD;

Jason Huo , PhD;

Sharon Mates , PhD;

Ian D'Souza , PhD;

Susan Kozauer , MD;

10/08/2020

Edinburgh Postnatal Depression Scale (EPDS) Total Score Remission and Number Needed to Treat (NNT) Outcomes in a Phase 3, Placebo-Controlled Trial of Zuranolone in Postpartum Depression (PPD)

Background: Zuranolone (SAGE-217) is an investigational, neuroactive steroid and GABAA receptor positive allosteric modulator evaluated in a Phase 3 trial in patients with PPD (NCT0297832...

Kristina Deligiannidis , MD;

Ellison Suthoff , MBA, BS ;

Stephen Kanes , MD, PhD;

Brian Werneburg , PhD;

Ming-Yi Huang , PhD;

Robert Lasser , MD, MBA;

Vijayveer Bonthapally , PhD;

Handan Gunduz-Bruce , MD, MBA;

Sarah Acaster , MSc;

Moshe Fridman , PhD;

10/08/2020

Cluster Analysis of Care Pathways in Major Depressive Disorder With Suicidal Ideation or Probable Suicide Attempt

BACKGROUND: To understand heterogeneity among the population with major depressive disorder (MDD) and suicidal ideation (SI) or attempt (SA) (MDD+SI/SA), clusters were identified through ...

Laura Morrison , MPH;

Maryia Zhdanava , MA;

Patrick Lefebvre , MA;

Dominic Pilon , MA;

Kruti Joshi , MPH, MD;

Cheryl Neslusan , PhD;

Tom Cornwall , PhD;

Maude Vermette-Laforme , BSc;

Abigail Nash , MD, PhD;

10/08/2020

Effects of Solriamfetol on Driving Performance in Participants With Narcolepsy

Introduction: Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the US and EU to improve wakefulness in adults with excessive daytime sleepiness (EDS) associated ...

Dandan Chen , MD, PhD;

Frederick Vinckenbosch , MSc;

Gert Jan Lammers , PhD, MD;

Sebastiaan Overeem , MD, PhD;

Grace Wang , MD, MS;

Lawrence Carter , PhD;

Kefei Zhou , PhD;

Johannes Ramaekers , PhD;

Annemiek Vermeeren , PhD;

10/08/2020

Educational Needs of Caregivers of Patients With Schizophrenia: Results of a National Survey Study

BACKGROUND: Caregivers of patients with schizophrenia are an often-overlooked target for education, but may be a key resource to promote therapeutic adherence and patient education. OBJE...

Emily Belcher , BS;

Sylvie Stacy , MD, MPH;

Mark Suett , MBChB, MRCP, DPM;

Marko Mychaskiw , PhD;

Gregory Salinas , PhD;

Leslie Citrome , MD;

10/08/2020

Creation of an Actionable Knowledge Toolkit for Evidence-Based Psychiatric Care

Objectives Measurement-based care (MBC) refers to using data from assessments to make clinical decisions. Recently the Relapse Assessment for Schizophrenia Patients (RASP), a patient sel...

Bre Banks , PhD;

Heidi Waters , PhD, MBA;

Kristin Pareja , PharmD;

Ruth Duffy , PhD;

10/08/2020

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products